Table of Contents: 1 Report Prologue 2 Executive Summary 3 Market Introduction 3.1 Definition 3.2 Scope of the Study 3.3 Assumptions & Limitations 3.3.1 Assumptions 3.3.2 Limitations 3.4 Market Structure 4 Research Methodology 4.1 Research Process 4.2 Primary Research 4.3 Secondary Research 4.4 Market Size Estimation 4.5 Forecast Model 5 Market Dynamics 5.1 Introduction 5.2 Drivers 5.2.1 Large Patient Population 5.2.2 Increasing Prevalence of Bacterial, Viral, and Fungal Infections 5.2.3 Rising Demand for Point of Care Diagnostic Services for Chronic Diseases 5.3 Restraints 5.3.1 Side-Effects of Antibiotics and Steroids 5.3.2 Lack of Awareness About Meningitis 5.4 Opportunities 5.4.1 Research for the Development of Specific Drugs for the Treatment of Meningitis 5.5 Technology Trends and Assessment 5.5.1 Increasing Focus on Combination Therapies 6 Market Factor Analysis 6.1.1 R&D and Designing 6.1.2 Manufacturing 6.1.3 Distribution & Sales 6.1.4 Post-Sales Monitoring 6.2 Porter’s Five Forces Model 6.2.1 Bargaining Power of Suppliers 6.2.2 Bargaining Power of Buyers 6.2.3 Threat of New Entrants 6.2.4 Threat of Substitutes 6.2.5 Intense Rivalry 6.3 Investment Opportunity Analysis 6.3.1 Market size (current and future), growth rate, and profitability 6.3.2 Investment Risks 6.3.3 Market Outlook 6.3.4 Competitors 6.3.5 Projections 6.4 Meningitis Tests (Number of tests for the Europe region) 7 Global Meningitis Diagnosis and Treatment Market, by Type 7.1 Introduction 7.2 Viral Meningitis 7.3 Bacterial Meningitis 7.4 Fungal Meningitis 8 Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis 8.1 Introduction 8.2 Treatment 8.2.1 Antibiotics 8.2.2 Steroids 8.2.3 Antifungal Drugs 8.3 Diagnosis 8.3.1 Spinal Tap (Lumbar Puncture) 8.3.2 Imaging Techniques 8.3.3 Blood Tests 9 Global Meningitis Diagnosis and Treatment Market, by End User 9.1 Introduction 9.2 Hospitals & Clinics 9.3 Diagnostic Centers 10 Global Meningitis Diagnosis and Treatment Market, by Region 10.1 Introduction 10.2 Americas 10.2.1 North America 10.2.1.1 US 10.2.1.2 Canada 10.2.2 Latin America 10.3 Europe 10.3.1 Western Europe 10.3.1.1 UK 10.3.1.2 France 10.3.1.3 Germany 10.3.1.4 Spain 10.3.1.5 Italy 10.3.1.6 Rest of Western Europe 10.3.2 Eastern Europe 10.4 Asia-Pacific 10.4.1 China 10.4.2 Japan 10.4.3 India 10.4.4 Australia 10.4.5 South Korea 10.4.6 Rest of Asia-Pacific 10.5 Middle East & Africa 10.5.1 Middle East 10.5.2 Africa 11 Competitive Landscape 11.1 Introduction 11.2 Company Market Share Analysis 12 Company Profiles 12.1 B. Braun Melsungen AG 12.1.1 Company Overview 12.1.2 Financial Overview 12.1.3 Products/Services Offered 12.1.4 Key Developments 12.1.5 SWOT Analysis 12.1.6 Key Strategy 12.2 Sanofi 12.2.1 Company Overview 12.2.2 Financial Overview 12.2.3 Products/Services Offered 12.2.4 Key Developments 12.2.5 SWOT Analysis 12.2.6 Key Strategy 12.3 Pfizer Inc. 12.3.1 Company Overview 12.3.2 Financial Overview 12.3.3 Products/Services Offered 12.3.4 Key Developments 12.3.5 SWOT Analysis 12.3.6 Key Strategy 12.4 Siemens Healthcare Private Limited 12.4.1 Company Overview 12.4.2 Financial Overview 12.4.3 Products/Services Offered 12.4.4 Key Developments 12.4.5 SWOT Analysis 12.4.6 Key Strategy 12.5 GlaxoSmithKline Plc. 12.5.1 Company Overview 12.5.2 Financial Overview 12.5.3 Products/Services Offered 12.5.4 Key Developments 12.5.5 SWOT Analysis 12.5.6 Key Strategy 12.6 Merck KGaA 12.6.1 Company Overview 12.6.2 Financial Overview 12.6.3 Products/Services Offered 12.6.4 Key Developments 12.6.5 SWOT Analysis 12.6.6 Key Strategy 12.7 Baxter 12.7.1 Company Overview 12.7.2 Financial Overview 12.7.3 Products/Services Offered 12.7.4 Key Developments 12.7.5 SWOT Analysis 12.7.6 Key Strategy 12.8 Abbott 12.8.1 Company Overview 12.8.2 Financial Overview 12.8.3 Products/Services Offered 12.8.4 Key Developments 12.8.5 SWOT Analysis 12.8.6 Key Strategy 12.9 Bio-Rad Laboratories Inc. 12.9.1 Company Overview 12.9.2 Financial Overview 12.9.3 Products/Services Offered 12.9.4 Key Developments 12.9.5 SWOT Analysis 12.9.6 Key Strategy 12.1 Thermo Fisher Scientific Inc. 12.10.1 Company Overview 12.10.2 Financial Overview 12.10.3 Products/Services Offered 12.10.4 Key Developments 12.10.5 SWOT Analysis 12.10.6 Key Strategy 12.11 Quest Diagnostics Incorporated 12.11.1 Company Overview 12.11.2 Financial Overview 12.11.3 Products/Services Offered 12.11.4 Key Developments 12.11.5 SWOT Analysis 12.11.6 Key Strategy 12.12 Luminex Corporation 12.12.1 Company Overview 12.12.2 Financial Overview 12.12.3 Products/Services Offered 12.12.4 Key Developments 12.12.5 SWOT Analysis 12.12.6 Key Strategy 12.13 F. Hoffmann-La Roche Ltd 12.13.1 Company Overview 12.13.2 Financial Overview 12.13.3 Products/Services Offered 12.13.4 Key Developments 12.13.5 SWOT Analysis 12.13.6 Key Strategy 12.14 Cepheid 12.14.1 Company Overview 12.14.2 Financial Overview 12.14.3 Products/Services Offered 12.14.4 Key Developments 12.14.5 SWOT Analysis 12.14.6 Key Strategy 13 Appendix 13.1 Discussion Blue Print

List of Tables: TABLE 1 MARKET SYNOPSIS TABLE 2 PRIMARY INTERVIEWS TABLE 3 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 4 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR VIRAL MENINGITIS, BY REGION, 2015–2023 (USD MILLION) TABLE 5 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR BACTERIAL MENINGITIS, BY REGION, 2015–2023 (USD MILLION) TABLE 6 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR FUNGAL MENINGITIS, BY REGION, 2015–2023 (USD MILLION) TABLE 7 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 8 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 9 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 10 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR TREATMENT, BY REGION, 2015–2023 (USD MILLION) TABLE 11 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR ANTIBIOTICS, BY REGION, 2015–2023 (USD MILLION) TABLE 12 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR STEROIDS, BY REGION, 2015–2023 (USD MILLION) TABLE 13 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR ANTIFUNGAL DRUGS, BY REGION, 2015–2023 (USD MILLION) TABLE 14 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR DIAGNOSIS, BY REGION, 2015–2023 (USD MILLION) TABLE 15 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR SPINAL TAP (LUMBAR PUNCTURE), BY REGION, 2015–2023 (USD MILLION) TABLE 16 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR IMAGING TECHNIQUES, BY REGION, 2015–2023 (USD MILLION) TABLE 17 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR BLOOD TESTS, BY REGION, 2015–2023 (USD MILLION) TABLE 18 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 19 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015–2023 (USD MILLION) TABLE 20 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2015–2023 (USD MILLION) TABLE 21 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2015–2023 (USD MILLION) TABLE 22 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2015–2023 (USD MILLION) TABLE 23 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 24 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 25 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 26 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 27 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 28 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY COUNTRY, 2015–2023 (USD MILLION) TABLE 29 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 30 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 31 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 32 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 33 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 34 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 35 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 36 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 37 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 38 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 39 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 40 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 41 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 42 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 43 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 44 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 45 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 46 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 47 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 48 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 49 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2015–2023 (USD MILLION) TABLE 50 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 51 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 52 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 53 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 54 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 55 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY COUNTRY, 2015–2023 (USD MILLION) TABLE 56 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 57 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 58 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 59 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 60 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 61 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 62 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 63 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 64 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 65 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 66 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 67 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 68 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 69 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 70 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 71 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 72 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 73 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 74 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 75 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 76 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 77 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 78 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 79 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 80 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 81 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 82 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 83 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 84 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 85 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 86 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 87 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 88 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 89 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 90 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 91 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 92 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 93 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 94 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 95 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 96 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY COUNTRY, 2015–2023 (USD MILLION) TABLE 97 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 98 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 99 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 100 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 101 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 102 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 103 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 104 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 105 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 106 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 107 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 108 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 109 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 110 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 111 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 112 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 113 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 114 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 115 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 116 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 117 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 118 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 119 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 120 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 121 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 122 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 123 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 124 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 125 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 126 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 127 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 128 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 129 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 130 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 131 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 132 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2015–2023 (USD MILLION) TABLE 133 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 134 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 135 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 136 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 137 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 138 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 139 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 140 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 141 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2015–2023 (USD MILLION) TABLE 142 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 143 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 144 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2015–2023 (USD MILLION) TABLE 145 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2015–2023 (USD MILLION) TABLE 146 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE 2015–2023, (USD MILLION) TABLE 147 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2015–2023 (USD MILLION)List of Figures: FIGURE 1 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET: MARKET STRUCTURE FIGURE 2 RESEARCH PROCESS FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH FIGURE 4 SUPPLY CHAIN: GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FIGURE 6 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY TYPE, 2017(%) FIGURE 7 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2017 & 2023 (USD MILLION) FIGURE 8 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY TREATMENT & DIAGNOSIS, 2017 (%) FIGURE 9 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2017 & 2023 (USD MILLION) FIGURE 10 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY END USER, 2017(%) FIGURE 11 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2017 & 2023 (USD MILLION) FIGURE 12 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2017(%) FIGURE 13 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2017 & 2023 (USD MILLION) FIGURE 14 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2017 (%) FIGURE 15 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2017 (%) FIGURE 16 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY COUNTRY, 2017 (%) FIGURE 17 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2017 (%) FIGURE 18 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, COMPANY MARKET SHARE ANALYSIS, 2017 (%)

Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Luminex Corporation, F. Hoffman-La Roche Ltd., Cepheid, and Pfizer Inc., B. Braun Melsungen AG, Sanofi, Pfizer Inc., Siemens Healthcare Private Limited, GlaxoSmithKline plc, Merck KGaA, Baxter, Abbott, Bio-Rad Laboratories Inc.